563 related articles for article (PubMed ID: 17767907)
1. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
2. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
4. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
[TBL] [Abstract][Full Text] [Related]
5. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling.
Canettieri G; Koo SH; Berdeaux R; Heredia J; Hedrick S; Zhang X; Montminy M
Cell Metab; 2005 Nov; 2(5):331-8. PubMed ID: 16271533
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
7. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
[TBL] [Abstract][Full Text] [Related]
8. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
Arai T; Ono Y; Arimura Y; Sayama K; Suzuki T; Shinjo S; Kanai M; Abe SI; Semba K; Goda N
Sci Rep; 2017 Feb; 7():42959. PubMed ID: 28218289
[TBL] [Abstract][Full Text] [Related]
9. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
10. Foxo1 integrates insulin signaling with mitochondrial function in the liver.
Cheng Z; Guo S; Copps K; Dong X; Kollipara R; Rodgers JT; Depinho RA; Puigserver P; White MF
Nat Med; 2009 Nov; 15(11):1307-11. PubMed ID: 19838201
[TBL] [Abstract][Full Text] [Related]
11. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.
Qadri I; Choudhury M; Rahman SM; Knotts TA; Janssen RC; Schaack J; Iwahashi M; Puljak L; Simon FR; Kilic G; Fitz JG; Friedman JE
J Biol Chem; 2012 Oct; 287(44):37340-51. PubMed ID: 22955269
[TBL] [Abstract][Full Text] [Related]
12. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
14. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.
Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H
J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
[TBL] [Abstract][Full Text] [Related]
16. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
18. FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.
Singh BK; Sinha RA; Zhou J; Xie SY; You SH; Gauthier K; Yen PM
J Biol Chem; 2013 Oct; 288(42):30365-30372. PubMed ID: 23995837
[TBL] [Abstract][Full Text] [Related]
19. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.
O-Sullivan I; Zhang W; Wasserman DH; Liew CW; Liu J; Paik J; DePinho RA; Stolz DB; Kahn CR; Schwartz MW; Unterman TG
Nat Commun; 2015 May; 6():7079. PubMed ID: 25963540
[TBL] [Abstract][Full Text] [Related]
20. A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism.
Cook JR; Matsumoto M; Banks AS; Kitamura T; Tsuchiya K; Accili D
Diabetes; 2015 Jun; 64(6):1951-65. PubMed ID: 25576059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
